Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) | AVESİS

Hacettepe University Research Information System

Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

Copy For Citation

Machiels J., Yen C., Licitra L., Rischin D., Waldron J., Burtness B., ...More

ESMO Immuno Oncology Congress, Geneva, Switzerland, 7 - 10 December 2017, vol.28

Publication Type: Conference Paper / Summary Text
Volume: 28
City: Geneva
Country: Switzerland
Hacettepe University Affiliated: Yes